Manuela Merli
#160,728
Most Influential Person Now
Researcher
Manuela Merli's AcademicInfluence.com Rankings
Manuela Merlicomputer-science Degrees
Computer Science
#9215
World Rank
#9681
Historical Rank
Machine Learning
#3978
World Rank
#4026
Historical Rank
Artificial Intelligence
#4312
World Rank
#4372
Historical Rank
Database
#6195
World Rank
#6423
Historical Rank
Download Badge
Computer Science
Manuela Merli's Degrees
- PhD Computer Science University of Milan
- Masters Computer Science University of Milan
- Bachelors Computer Science University of Milan
Similar Degrees You Can Earn
Why Is Manuela Merli Influential?
(Suggest an Edit or Addition)Manuela Merli's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. (2003) (538)
- Incidence and natural history of small esophageal varices in cirrhotic patients. (2003) (519)
- Factors associated with poor health-related quality of life of patients with cirrhosis. (2001) (474)
- EASL Clinical Practice Guidelines on nutrition in chronic liver disease. (2019) (450)
- ESPEN guidelines for nutrition in liver disease and transplantation. (1997) (423)
- Sarcopenia from mechanism to diagnosis and treatment in liver disease. (2016) (380)
- Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites (2004) (316)
- Does malnutrition affect survival in cirrhosis? (1996) (303)
- ESPEN guideline on clinical nutrition in liver disease. (2019) (287)
- Cirrhotic patients are at risk for health care-associated bacterial infections. (2010) (284)
- Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial (2018) (272)
- MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. (2002) (256)
- Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation. (2005) (254)
- Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial (2015) (253)
- Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide. (2019) (237)
- Nutritional status: its influence on the outcome of patients undergoing liver transplantation (2010) (226)
- Incidence, Natural History, and Risk Factors of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt With Polytetrafluoroethylene-Covered Stent Grafts (2008) (225)
- Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study. (2005) (186)
- Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study (2013) (184)
- Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: A randomized multicenter trial (1998) (184)
- Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe. (2019) (183)
- A practical approach to nutritional screening and assessment in cirrhosis (2017) (179)
- Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis. (2014) (176)
- High prevalence of spontaneous portal‐systemic shunts in persistent hepatic encephalopathy: A case‐control study (2005) (164)
- Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi). (1996) (147)
- Basal energy production rate and substrate use in stable cirrhotic patients (1990) (146)
- The PREDICT study uncovers three clinical courses in acutely decompensated cirrhosis with distinct pathophysiology (120/120). (2020) (146)
- Modification of cardiac function in cirrhotic patients with and without ascites (2000) (146)
- Sarcopenia in liver cirrhosis: the role of computed tomography scan for the assessment of muscle mass compared with dual-energy X-ray absorptiometry and anthropometry (2015) (141)
- Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis. (2019) (129)
- Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement (2017) (128)
- Malnutrition is a risk factor in cirrhotic patients undergoing surgery. (2002) (128)
- Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy. (2003) (121)
- Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial. (2010) (117)
- Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice. (2008) (115)
- Iron overload in patients with chronic viral hepatitis: how common is it? (1997) (112)
- The Natural History of Portal Hypertensive Gastropathy in Patients with Liver Cirrhosis and Mild Portal Hypertension (2004) (107)
- Optimal nutritional indexes in chronic liver disease. (1987) (104)
- Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy. (2011) (100)
- Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients. (1990) (98)
- ESPEN practical guideline: Clinical nutrition in liver disease. (2020) (98)
- PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis. (2020) (98)
- Depression, anxiety and alexithymia symptoms are major determinants of health related quality of life (HRQoL) in cirrhotic patients (2013) (96)
- A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C. (2007) (96)
- Zinc supplementation reduces blood ammonia and increases liver ornithine transcarbamylase activity in experimental cirrhosis (1992) (95)
- The chronic use of beta‐blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis (2015) (91)
- Total parenteral nutrition-related gastroenterological complications. (2006) (89)
- Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation (1999) (89)
- Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS) (2002) (89)
- QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt. (2003) (87)
- The Spread of Multi Drug Resistant Infections Is Leading to an Increase in the Empirical Antibiotic Treatment Failure in Cirrhosis: A Prospective Survey (2015) (87)
- Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy (1991) (86)
- Diagnosis, treatment and survival of patients with hepatorenal syndrome: a survey on daily medical practice. (2011) (84)
- Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology (SIGE). (2005) (83)
- Cholestasis induced by total parenteral nutrition. (2008) (83)
- Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C (2008) (82)
- Multiclass HCV resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapies (2017) (82)
- Ongoing Prothrombotic State in the Portal Circulation of Cirrhotic Patients (1997) (82)
- Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (1996) (81)
- Validation of automated blood cell counter for the determination of polymorphonuclear cell count in the ascitic fluid of cirrhotic patients with or without spontaneous bacterial peritonitis (2003) (80)
- Cardiac dysfunction in cirrhosis is not associated with the severity of liver disease. (2013) (80)
- Glucose intolerance in liver cirrhosis. (1982) (78)
- Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. (2012) (76)
- Polytetrafluoroethylene-Covered Stent Grafts for TIPS Procedure: 1-Year Patency and Clinical Results (2004) (76)
- Increased risk of cognitive impairment in cirrhotic patients with bacterial infections. (2013) (75)
- Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis (2019) (73)
- A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients. (2017) (70)
- Transjugular intrahepatic portosystemic shunt with expanded-polytetrafuoroethylene-covered stents in non-cirrhotic patients with portal cavernoma. (2011) (66)
- Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt (2019) (65)
- Does malnutrition affect survival in cirrhosis (1996) (65)
- An empirical broad spectrum antibiotic therapy in health‐care–associated infections improves survival in patients with cirrhosis: A randomized trial (2015) (65)
- Malnutrition is not related to alterations in energy balance in patients with stable liver cirrhosis. (2003) (65)
- Sarcopenia and frailty in decompensated cirrhosis. (2021) (64)
- Malabsorption and nutritional abnormalities in patients with liver cirrhosis. (1990) (63)
- Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis (2018) (62)
- Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis. (2020) (62)
- GFAP expression in the liver as an early marker of stellate cells activation. (2005) (59)
- Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF). (2019) (57)
- Splanchnic and leg exchange of free fatty acids in patients with liver cirrhosis. (1986) (54)
- Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation. (2004) (51)
- Cognitive Impairment Predicts The Occurrence Of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (2016) (51)
- Influence of leucine infusion on intracellular amino acids in humans (1990) (51)
- Carbon tetrachloride-induced experimental cirrhosis in the rat: a reappraisal of the model. (1989) (50)
- Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure. (2020) (49)
- Combining amplicon sequencing and metabolomics in cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy (2018) (48)
- Total and individual free fatty acid concentrations in liver cirrhosis. (1984) (47)
- Peripheral and Splanchnic Indole and Oxindole Levels in Cirrhotic Patients: A Study on the Pathophysiology of Hepatic Encephalopathy (2009) (47)
- A Model for Predicting Development of Overt Hepatic Encephalopathy in Patients With Cirrhosis. (2015) (47)
- Changes in nutritional status after liver transplantation. (2014) (47)
- RIFLE criteria and hepatic function in the assessment of acute renal failure in liver transplantation. (2010) (47)
- Cost analysis for the prevention of variceal rebleeding: A comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy in a selected group of italian cirrhotic patients (1999) (46)
- Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health‐related quality of life in cirrhotic patients (2011) (46)
- Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study. (2004) (46)
- Endoscopic screening for esophageal varices in cirrhotic patients (2002) (46)
- NADPH oxidase‐mediated platelet isoprostane over‐production in cirrhotic patients: implication for platelet activation (2011) (45)
- Effect of sodium benzoate on blood ammonia response to oral glutamine challenge in cirrhotic patients: a note of caution (2000) (43)
- A comparison of skinfold anthropometry and dual-energy X-ray absorptiometry for the evaluation of body fat in cirrhotic patients. (1999) (43)
- Whole body and regional body composition analysis by dual-energy X-ray absorptiometry in cirrhotic patients (1997) (42)
- Effect of a Medium Dose of Ursodeoxycholic Acid with or without Taurine Supplementation on the Nutritional Status of Patients with Cystic Fibrosis: A Randomized, Placebo‐Controlled, Crossover Trial (1994) (42)
- Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.). (1998) (42)
- The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPS (2019) (42)
- Bone disorders in patients with chronic liver disease awaiting liver transplantation. (2010) (42)
- PREDICTIVE FACTORS OF OUTCOME AFTER LIVER TRANSPLANTATION IN PATIENTS WITH CIRRHOSIS AND HEPATOCELLULAR CARCINOMA (2004) (42)
- A low muscle mass increases mortality in compensated cirrhotic patients with sepsis (2018) (42)
- Beta-blockers in liver cirrhosis (2014) (41)
- Recent Developments in Trace Element Analysis in the Prevention, Diagnosis, and Treatment of Diseases (1998) (39)
- Dietary and nutritional indications in hepatic encephalopathy (2009) (39)
- Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis. (2018) (38)
- Hepatic Encephalopathy and Sarcopenia: Two Faces of the Same Metabolic Alteration. (2019) (36)
- Hepatic encephalopathy expands the predictivity of model for end‐stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts (2016) (34)
- Branched-chain amino acids vs lactulose in the treatment of hepatic coma (1982) (34)
- Nutritional status and liver transplantation. (2011) (33)
- Survival at 2 years among liver cirrhotic patients is influenced by left atrial volume and left ventricular mass (2017) (33)
- Sarcopenic obesity in fatty liver (2019) (32)
- Hepatic encephalopathy: Lack of changes of γ‐aminobutyric acid content in plasma and cerebrospinal fluid (1987) (32)
- Sarcopenia in non-alcoholic fatty liver disease: Targeting the real culprit? (2015) (32)
- Zinc and other trace elements in liver cirrhosis. (1991) (31)
- Use of elderly donors for liver transplantation: has the limit been reached? (2011) (30)
- Improvement of nutritional status in malnourished cirrhotic patients one year after liver transplantation (2011) (30)
- Immune-mediated liver dysfunction after antiviral treatment in liver transplanted patients with hepatitis C: allo or autoimmune de novo hepatitis? (2009) (30)
- Chronic Kidney Disease After Liver Transplantation: Pretransplantation Risk Factors and Predictors During Follow-Up (2013) (29)
- MuRF‐1 and p‐GSK3β expression in muscle atrophy of cirrhosis (2013) (27)
- Early postprandial energy expenditure and macronutrient use after a mixed meal in cirrhotic patients. (1992) (27)
- Predictive factors of recurrence of hepatocellular carcinoma after liver transplantation: a multivariate analysis. (2009) (27)
- A simplified psychometric evaluation for the diagnosis of minimal hepatic encephalopathy. (2011) (27)
- The effects of alcohol on gastrointestinal tract, liver and pancreas: evidence-based suggestions for clinical management. (2015) (27)
- Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation (2021) (26)
- Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal-systemic shunt (1989) (26)
- Accuracy of the automated cell counters for management of spontaneous bacterial peritonitis. (2008) (26)
- Circulating anti-insulin receptor antibodies in a patient suffering from lupus nephritis and hypoinsulinemic hypoglycaemia. (1983) (26)
- What is new about diet in hepatic encephalopathy (2016) (26)
- Metabolic syndrome and cardiovascular risk after liver transplantation: a single-center experience. (2012) (25)
- Plasma and cerebrospinal fluid amino acid patterns in hepatic encephalopathy (1982) (25)
- Preharvest donor hyperoxia predicts good early graft function and longer graft survival after liver transplantation (2005) (24)
- Effect of lactitol on blood ammonia response to oral glutamine challenge in cirrhotic patients: evidence for an effect of nonabsorbable disaccharides on small intestine ammonia generation (1999) (24)
- Patient and physician views on the quality of care in inflammatory bowel disease: results from SOLUTION-1, a prospective IG-IBD study. (2014) (23)
- On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites. (2020) (22)
- Effect of Blood Ammonia Elevation Following Oral Glutamine Load on the Psychometric Performance of Cirrhotic Patients (2003) (22)
- Skeletal muscle myopenia in mice model of bile duct ligation and carbon tetrachloride‐induced liver cirrhosis (2017) (22)
- Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver. (2020) (21)
- No effect of albumin infusion on the prevention of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (2016) (21)
- Advances in Hepatic Encephalopathy and Metabolic Nitrogen Exchange (1994) (19)
- Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactulose. (1990) (19)
- Predictors of mortality in non-neutropenic patients with invasive pulmonary aspergillosis: does galactomannan have a role? (2014) (19)
- Phagocytosis of gadolinium chloride or zymosan induces simultaneous upregulation of hepcidin- and downregulation of hemojuvelin- and Fpn-1-gene expression in murine liver (2009) (19)
- Hepatic encephalopathy in patients with non-cirrhotic portal hypertension: Description, prevalence and risk factors. (2016) (18)
- Conversion from twice-daily to once-daily tacrolimus administration in liver transplant patient. (2010) (18)
- The Effect of 12 Weeks of β-Hydroxy-β-Methyl-Butyrate Supplementation after Liver Transplantation: A Pilot Randomized Controlled Study (2019) (18)
- Acute renal failure in liver transplant recipients: role of pretransplantation renal function and 1-year follow-up. (2011) (17)
- Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study. (2017) (17)
- Increased nonoxidative glucose metabolism in idiopathic reactive hypoglycemia. (1996) (17)
- The effect of lactulose and lactitol administration on fecal fat excretion in patients with liver cirrhosis. (1992) (17)
- Donor-to-recipient gender match in liver transplantation: A systematic review and meta-analysis (2018) (17)
- Combined liver-kidney transplantation in polycystic disease: case reports. (2008) (16)
- Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study. (2019) (16)
- The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease. (2019) (16)
- The multidisciplinary support in preventing alcohol relapse after liver transplantation: A single‐center experience (2018) (16)
- Long Term Dietary Supplement with Branched Chain Amino Acids: A New Approach in the Prevention of Hepatic Encephalopathy: Results of a Controlled Study in Cirrhotics with Porto-Caval Anastomosis (1984) (15)
- Aminoacid imbalance and malnutrition in liver cirrhosis. (1985) (15)
- Long-term effect of liver transplantation on cirrhotic autonomic cardiac dysfunction. (2010) (15)
- Session 8 ‒ Complications in the Medical Treatment of Portal Hypertension (2008) (15)
- Conversion from twice-daily to once-daily Tacrolimus administration in liver transplant patient: results of long term follow-up. (2012) (14)
- Does cirrhotic cardiomyopathy exist? 50 years of uncertainty (2013) (14)
- Hepatic encephalopathy (2022) (14)
- Bacterial resistance in cirrhotic patients: an emerging reality. (2012) (14)
- Impaired nonoxidative glucose metabolism in patients with liver cirrhosis: effects of two insulin doses. (1997) (14)
- MRI reveals different Crohn’s disease phenotypes in children and adults (2019) (14)
- Management of hepatic encephalopathy. (1997) (14)
- Prevalence and impact of sarcopenia in non‐cirrhotic portal hypertension (2019) (13)
- Graft macrosteatosis and time of T‐tube removal as risk factors for biliary strictures after liver transplantation (2013) (13)
- Nutritional status in liver cirrhosis. (1993) (13)
- The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (2021) (13)
- Fatty acid composition of adipose tissue in patients with chronic liver disease. (1986) (12)
- Epidemiology, predictors and outcomes of multi drug resistant (MDR) bacterial infections in patients with cirrhosis across the world : final results of the 'Global study' (2018) (12)
- Circadian rhythmicity of plasma amino acid variations in healthy subjects. (1989) (12)
- Intractable Hepatic Encephalopathy After Tips with Polytetrafluoroethylene-covered Stent-Graft (2003) (12)
- Increased energy expenditure in cirrhotic patients with hepatocellular carcinoma. (1992) (12)
- Recipient Interleukin-28B Rs12979860 C/T Polymorphism and Acute Cellular Rejection After Liver Transplantation: Role of the Calcineurin Inhibitor Used (2012) (11)
- Resistance to insulin suppression of plasma free fatty acids in liver cirrhosis (1990) (11)
- Occurrence of chronic renal failure in liver transplantation: monitoring of pre- and posttransplantation renal function. (2012) (11)
- Differential vascular endothelial growth factor A protein expression between small hepatocellular carcinoma and cirrhosis correlates with serum vascular endothelial growth factor A and α‐fetoprotein (2009) (11)
- Long‐term outcomes of direct acting antivirals in post‐transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis (2017) (11)
- Liver transplantation for severe alcoholic hepatitis: A multicenter Italian study (2021) (10)
- Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients (2012) (10)
- Ribavirin Priming Improves the Virological Response to Antiviral Treatment in Transplanted Patients with Recurrent Hepatitis C: A Pilot Study (2011) (10)
- Atorvastatin-Induced Prolonged Cholestasis with Bile Duct Damage (2010) (10)
- Polyunsaturated fatty acids balance affects platelet NOX2 activity in patients with liver cirrhosis. (2014) (10)
- Failure of hepatitis B vaccination to induce either humoral or cellular immune response after liver transplantation for hepatitis B related cirrhosis. (2005) (9)
- Presence of multiple bacterial markers in clinical samples might be useful for presumptive diagnosis of infection in cirrhotic patients with culture-negative reports (2016) (9)
- Intravascular hemolysis and transjugular intrahepatic portosystemic stent shunt. (1994) (9)
- Performance of the model for end-stage liver disease score for mortality prediction and the potential role of etiology. (2021) (9)
- Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis (2016) (9)
- Branched-Chain Amino Acids in the Treatment of Severe Hepatic Encephalopathy (1984) (9)
- Outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma. (2007) (9)
- Use of the stable isotope 65Cu test for the screening of Wilson's disease in a family with two affected members. (1998) (8)
- Treatment of genotype‐1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers (2013) (8)
- Muscle mass vs. adipose tissue to predict outcome in cirrhosis: Which matters and in which patients? (2018) (8)
- Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patients. (1998) (8)
- Weight Gain and De Novo Metabolic Disorders after Liver Transplantation (2019) (7)
- Clinical nutrition practice in Italian Gastroenterology Units. (2000) (7)
- Emergency laser vaporization and helium-oxygen administration for acute malignant tracheobronchial obstruction. (1989) (7)
- Pediatric sarcopenia: exploring a new concept in children with chronic liver disease (2019) (7)
- Management of hepatic encephalopathy as an inpatient (2015) (7)
- A cost analysis of a broad-spectrum antibiotic therapy in the empirical treatment of health care-associated infections in cirrhotic patients (2017) (6)
- Distribution of natural resistance to NS3 protease inhibitors in hepatitis C genotype 1a separated into clades 1 and 2 and in genotype 1b of HIV-infected patients. (2016) (6)
- Session 2: Predictive Models in Portal Hypertension (2007) (6)
- P473 BACTERIAL INFECTIONS IN CIRRHOTIC PATIENTS: RISK FACTORS AND RATE OF FAILURE OF THE EMPIRICAL ANTIBIOTIC THERAPY (2014) (6)
- The Effects of 12-Week Beta-Hydroxy-Beta-Methylbutyrate Supplementation in Patients with Liver Cirrhosis: Results from a Randomized Controlled Single-Blind Pilot Study (2021) (6)
- Spontaneous Bacterial Peritonitis Due to Methicillin-Resistant Staphylococcus Aureus in a Patient with Cirrhosis: The Potential Role for Daptomycin and Review of the Literature (2015) (6)
- MELDNa score is associated with psychopathology and reduced quality of life in cirrhotic patients with a liver transplant perspective (2017) (6)
- Albumin administration in the prevention of hepatorenal syndrome (HRS) and death in patients with advanced cirrhosis and non-SBP infections (2018) (6)
- What is the impact of malnutrition on survival in liver cirrhosis (1994) (6)
- Ischemic Damage Represents the Main Risk Factor for Biliary Stricture After Liver Transplantation: A Follow-Up Study in a Danish Population (2018) (5)
- Recipient perioperative cholesterolaemia and graft cholesterol metabolism gene expression predict liver transplant outcome (2014) (5)
- Is hyperammonemia really the true cause of altered neuropsychology, brain MR spectroscopy and magnetization transfer after an oral amino acid load in cirrhosis? (2003) (5)
- Cholemic Nephropathy as Cause of Acute and Chronic Kidney Disease. Update on an Under-Diagnosed Disease (2021) (5)
- TIPS versus paracentesis in the treatment of refractory ascites: Preliminary results of a randomized controlled trial (2000) (5)
- Outcomes of long‐term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis (2020) (5)
- 201 COMBINED THERAPY WITH LOW DOSE HEPATITIS B IMMUNOGLOBULIN (HBIG) AND LAMIVUDINE (LAM) IN PATIENTS TRANSPLANTED FOR HBV CHRONIC LIVER DISEASE: LONG TERM EFFICACY AND COSTS (2008) (5)
- Ammonia and the Muscle: An Emerging Point of View on Hepatic Encephalopathy (2022) (5)
- Microbial translocation and T cell activation are modified by direct‐acting antiviral therapy in HCV‐infected patients (2018) (5)
- Epidemiology, predictors and outcomes of multi drug resistant bacterial infections in patients with cirrhosis across the world. Final results of the “Global study” (2018) (5)
- Hemostasis in uncontrolled esophageal variceal bleeding by self−expanding metal stents: a systematic review (2016) (5)
- Donor Small-Droplet Macrovesicular Steatosis Affects Liver Transplant Outcome in HCV-Negative Recipients (2019) (5)
- Ten years’ activity of the first Italian public hospice for terminally ill patients (2004) (4)
- Nutritional Assessment and Management for Hospitalized Patients with Cirrhosis (2018) (4)
- Albumin infusion in cirrhotic patients with infections other than spontaneous bacterial peritonitis: End of the story? (2015) (4)
- 100 Peginterferon alfa-2A (40KD) with or without ribavirin in the treatment of recurrent hepatitis C after liver transplantation: Preliminary report of a randomized study (2004) (4)
- Risk of falls in patients with cirrhosis evaluated by timed up and go test: Does muscle or brain matter more? (2021) (4)
- Nutrition in cirrhosis: Dos and Don'ts. (2020) (4)
- PTFE-covered stent-grafts for tips procedure: One-year patency and clinical results (2003) (4)
- PC.01.7 BACTERIAL INFECTIONS IN CIRRHOTIC PATIENTS: RISK FACTORS AND RATE OF FAILURE OF THE EMPIRICAL ANTIBIOTIC THERAPY (2014) (4)
- Nutrient utilization in liver cirrhosis: what impact on nutritional status? (1994) (4)
- Editorial: von Willebrand factor and CRP levels may predict survival in liver cirrhosis (2018) (3)
- Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C. (2014) (3)
- Sarcopenia Represents a Risk Factor for the Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (2017) (3)
- OC-29 Terlipressin and albumin vs midodrine plus octreotide and albumin in the treatment of hepatorenal syndrome in patients with cirrhosis: results of a controlled clinical trial by A.I.S.F. (2012) (3)
- Impact of anti-hepatitis B core-positive donors in liver transplantation: a survival analysis. (2011) (3)
- Preliminary results of a randomised controlled trials in the prevention of early post-TIPS hepatic encephalopathy: A comparison between rifaximin and lactitol (2002) (3)
- Interaction between infection and hepatic encephalopathy. (2015) (3)
- [Transjugular intrahepatic porto-systemic shunt (TIPS): indications and results]. (1994) (3)
- Do we really need alternatives to polymorphonuclear cells counting in ascitic fluid? (2009) (3)
- Prevalent use of combined prophylaxis of hepatitis B after liver transplantation in Italy: results of a national survey in a large cohort. (2018) (3)
- Nutritional Therapy in the Management of Physical Frailty and Sarcopenia (2019) (2)
- Multiclass hepatitis C virus resistance to direct acting antivirals in real life interferon-free regimens failures advocates for tailored second-line therapies (2017) (2)
- Comparison of Up-to-seven criteria with Milan Criteria for liver transplantation in patients with HCC (2021) (2)
- Composition of free fatty acids and adipose tissue triglycerides in portacaval shunted rats. (1987) (2)
- Sarcopenia in chronic advanced liver diseases: A sex-oriented analysis of the literature (2021) (2)
- Cumulative incidence of solid and hematological De novo malignancy after liver transplantation in a multicentre cohort. (2021) (2)
- Hemodynamic Evaluation of the Right Heart-Pulmonary Circulation Unit in Patients Candidate to Transjugular Intrahepatic Portosystemic Shunt (2022) (2)
- TIPS for patients awaiting orthotopic liver transplantation (2003) (2)
- Zinc supplmentation reduces blood ammonia and increases liver ornithine transcarbamylase (OTC) in experimental cirrhosis (1990) (2)
- Tips vs sclerotherapy for prevention of variceal re-bleeding Results of a randomized controlled trial (1996) (2)
- Does the gut microbiota modulate the inflammatory state in cirrhotic host (2014) (2)
- Malnutrition in Chronic Liver Disease (1985) (2)
- Cognitive Impairment Predicts the Occurrence of Hepatic Encephalopathy after Transjugular Intrahepatic Portosysthemic Shunt (2016) (2)
- Enoxaparin for thromboprophylaxis in hospitalized COVID-19 patients: comparison of 40 mg o.d. vs 40 mg b.i.d. The X-COVID19 Randomized Clinical Trial (2021) (2)
- [Pathogenesis of hepatic coma]. (1981) (2)
- Adherence to EASL antibiotic treatment recommendations improves the outcomes of patients with cirrhosis and bacterial infections. Results from the ICA Global Study (2018) (2)
- Primary Prophylaxis of First Variceal Bleeding (2016) (1)
- [The European Association for the Study of Liver (EASL) nutrition guidelines.] (2021) (1)
- Reply to: “The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites” (2021) (1)
- TIPS: Refractory Ascites and Encephalopathy (2000) (1)
- Energy expenditure and food intake in patients with stable cirrhosis with or without malnutrition (2000) (1)
- Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS (2022) (1)
- MuRF-1 and p-GSK3β expression in muscle atrophy of liver cirrhosis (1)
- Nutrition in Liver Cirrhosis and Transplantation—Current State and Knowledge Gaps (2020) (1)
- F-14Multiclass HCV resistance to interferon-free direct acting antivirals regimens in real life failures advocates for tailored second-line therapies (2017) (1)
- Differential VEGF-A protein expression between small HCC and cirrhosis at distance from the tumor correlates with serum VEGF-A and alpha-fetoprotein (2008) (1)
- Outbreak of Acute Hepatitis A involving young men in Lombardy region, Italy: Risk factors, clinical and virological characteristics (2018) (1)
- Nutrition and Hepatic Encephalopathy (2012) (1)
- Virological Failures to New Direct Acting Antivirals in a Real Life Setting May Require Unconventional Regimens for Re-Treatment (2016) (1)
- May sarcopenia and/or hepatic encephalopathy improve the predictivity of model for end-stage liver disease? (2018) (1)
- 158 RESPONSE PREDICTION IN CHRONIC HEPATITIS C AFTER LIVER TRANSPLANT BY ASSESSMENT ENT-1-RELATED SINGLE NUCLEOTIDE POLYMORPHISMS (2013) (1)
- Presence of resistance associated variants in patients with virological failure to new direct acting antivirals and requirement of unconventional regimens for re-treatment (2016) (1)
- Is the multidisciplinary support effective in preventing alcohol relapse after liver transplantation (2017) (1)
- Increased resting energy expenditure in patients with hepato cellular carcinoma (1990) (1)
- The European Society for Clinical Nutrition and Metabolism practical guideline: Clinical nutrition in liver disease (2021) (1)
- P41 DOES THE GUT MICROBIOTA MODULATE THE INFLAMMATORY STATE IN CIRRHOTIC HOST (2014) (1)
- Continuous infusion of beta-lactam antibiotics in cirrhotic patients with bloodstream infection: results from a prospective multicentre observational study (2018) (1)
- Macronutrient oxidation in liver disease. (1993) (1)
- P: 25 Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis (2019) (1)
- 157 BONE DISORDERS BEFORE AND AFTER LIVER TRANSPLANTATION (2013) (1)
- 532 POOR ADHERENCE TO PEGYLATED-INTERFERON AND RIBAVIRIN IS A MAJOR CONCERN IN THE TREATMENT OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION: EVIDENCE FROM THE RECOLT-C GROUP (2011) (1)
- 204 Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (tips): PTFE-covered stent grafts versus bare stents (2006) (1)
- Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria (2022) (1)
- Liver, Pancreas and Biliary Tract Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation (2005) (1)
- 220 Randomised controlled trial for the prevention of hepatic encephalopathy after transjugular intrahepatic porto-systemic shunt (TIPS): Comparison between lactitol, rifaximin and no treatment (2004) (1)
- Regional variations in the development of acute-on-chronic liver failure (ACLF) in patients with cirrhosis and bacterial infections (2018) (1)
- Measurement of resting energy expenditure in patients with liver disease. (1991) (1)
- LP51 : Treatment of severe HCV recurrence after liver transplantation with sofosbuvir based regimen: Results of the aisf-sofolt Italian compassionate use program (2015) (1)
- 296 EFFICACY OF ASCITES CLUB GUIDELINES FOR THE TREATMENT OF SPONTANEOUS BACTERIAL PERITONITIS IN THE CLINICAL PRACTICE (2008) (1)
- TPN-related digestive complications in critically ill patients (2006) (1)
- Chronic renal dysfunction after liver transplantation: Incidence and risk factors (2007) (1)
- [Assessment of the relationship between health personnel and caregivers caring for dementia patients. Results of a pilot survey]. (2001) (1)
- P513 A SIMPLE MODEL FOR THE PREDICTION OF OVERT HEPATIC ENCEPHALOPATHY IN CIRRHOTIC PATIENTS: RESULTS OF A PROSPECTIVE OBSERVATIONAL STUDY AND VALIDATION IN AN INDEPENDENT COHORT (2014) (1)
- The assessment of Sarcopenia by quadriceps muscle ultrasound in patients with liver cirrhosis (2018) (1)
- FRI-428-Prevalence and impact of sarcopenia in non-cirrhotic portal hypertension (2019) (1)
- Donor liver small droplet macrovesicular steatosis is associated with reduced graft survival after liver transplantation (2018) (1)
- The amelioration of muscle wasting leads to the improvement of cognitive impairment after transjugular intrahepatic portosystemic shunt: A proof of concept that sarcopenia and hepatic encephalopathy are causally related (2018) (1)
- Nitrogen excretion in cirrhotic patients during non-absorbable disaccharide administration. A comparison between lactulose and lactitol (1995) (1)
- T06.01.7 TRANSVERSAL PSOAS MUSCLE THICKNESS AND SKELETAL MUSCLE INDEX, A COMPARISON OF TWO TOLL FOR THE DIAGNOSIS OF SARCOPENIA IN CIRRHOSIS (2020) (0)
- T.N.49 FIBROSIS PROGRESSION IN NON RESPONDERS TO ANTIVIRAL TREATMENT (AT) FOR HCV RECURRENCE FOLLOWING LIVER TRANSPLANTATION (LT) (2010) (0)
- Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections in Patients With Liver Cirrhosis. (2022) (0)
- P0064 : Ribavirin pre-treatment in liver transplant patients with hcv recurrence: Results from pearl multicentre randomized trial (2015) (0)
- Does nutritional status influence the outcome in patients undergoing liver transplantation in the “MELD” era? (2007) (0)
- Beta‐blockers in patients with cirrhosis and infections: don't blame too soon! (2015) (0)
- The role of liver stiffness by ARFI elastography in the diagnosis of porto-sinusoidal vascular disease: comparison with patients with chronic portal vein thrombosis (2020) (0)
- PRE-TRANSPLANT HEPATIC FUNCTION AND ACUTE RENAL FAILURE IN LIVER TRANSPLANTATION (2010) (0)
- Intraoperative histological ischemia–reperfusion injury assessment but not clinical early allograft dysfunction predicts graft loss only in HCV positive recipients submitted to liver transplant (2014) (0)
- Role of extracellular vesicles in sarcopenia associated to chronic liver diseases (2023) (0)
- From meetings (1988) (0)
- 474 THE PREDICTION OF CHRONIC RENAL DYSFUNCTION FOLLOWING LIVER TRANSPLANTATION: A TIME-DEPENDENT ANALYSIS (2010) (0)
- Fluctuations of Estimated Glomerular Filtration Rate Outside Kidney Disease Improving Global Outcomes Diagnostic Criteria for Acute Kidney Injury in End-Stage Liver Disease Outpatients and Outcome Postliver Transplantation (2017) (0)
- [83] MOLECULAR STUDY OF HEPATOCELLULAR CHOLESTEROL HOMEOSTASIS IN HUMAN LIVER TRANSPLANTATION (2009) (0)
- Hyperdynamic circulation after tips implantation: its effects on neurohumoral system (2002) (0)
- P: 26 The Modification of Quantity and Quality of Muscle Mass Improves the Cognitive Impairment After TIPS (2019) (0)
- Vascular liver diseases: A sex-oriented analysis of the literature. (2022) (0)
- MARS TREATMENT IN AOCHF PATIENTS ON TX WAITING LIST IMPROVES MELD SCORE (2006) (0)
- Zinc supplementation modifies liver ornithine transcarbamylase (OTC) activity and ammonia disposal in experimental cirrhosis (1991) (0)
- P.146 BACTERIAL INFECTIONS AND SEPSIS ACUTELY DETERIORATE LIVER FUNCTION IN CIRRHOTIC PATIENTS: A PROSPECTIVE STUDY (2010) (0)
- 13 Long-term oral BCAA supplements in advanced cirrhosis. A double-blind, randomized trial (2003) (0)
- P.06.28 PREDICTIVE FACTORS FOR THE ERADICATION OF ESOPHAGEAL VARICES IN CIRRHOTIC PATIENT UNDERGOING ENDOSCOPIC BAND LIGATION (2018) (0)
- Determinants of clinical efficacy of empirical antibiotic treatment in patients with cirrhosis and bacterial infections: Results from the ICA global study (2018) (0)
- P.03.14 COMBINED THERAPY WITH LOW DOSE HEPATITIS B IMMUNOGLOBULIN AND LAMIVUDINE IN PATIENTS TRANSPLANTED FOR HBV END STAGE LIVER DISEASE: STILL COST-EFFECTIVE? (2012) (0)
- The European Society for Clinical Nutrition and Metabolism practical guideline: Clinical nutrition in liver disease. Part 2 (0)
- Role of the determination of partial pressure of ammonia in cirrhotic patients with hepatic encephalopathy (2002) (0)
- VIRONET-C real life experience of resistance-guided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimen (2020) (0)
- Physiopathogenic, Clinical and Practical Aspects of Hepatic Encephalopathy (2010) (0)
- Muscle and fat depletion in liver cirrhosis (1990) (0)
- P.147 MELD, PROTEIN MALNUTRITION AND PREVIOUS INFECTIONS ARE PREDICTORS OF BACTERIAL INFECTIONS AND SEPSIS IN CIRRHOTIC PATIENTS (2010) (0)
- O9 BACTERIAL INFECTIONS INDUCE BOTH OVERT AND MINIMAL HEPATIC ENCEPHALOPATHY: RESULTS OF A PROSPECTIVE STUDY (2012) (0)
- Response to Drs. Piscaglia et al. (2001) (0)
- Natural history of the progression of liver disease in cirrhotic patients (2000) (0)
- Is obesity an additional negative factor in sarcopenic cirrhotic patients (2018) (0)
- OC.03.5 COGNITIVE IMPAIRMENT PREDICTS THE OCCURRENCE OF HEPATIC ENCEPHALOPATHY AFTER TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (2016) (0)
- P474 CLINICAL OUTCOMES OF PATIENTS WITH PORTAL HYPERTENSION NOT DUE TO CIRRHOSIS: A SINGLE-CENTRE EXPERIENCE (2014) (0)
- Serum leptin levels in cirrhosis (2000) (0)
- Tu1182 PREDICTIVE FACTORS FOR THE ERADICATION OF ESOPHAGEAL VARICES IN CIRRHOTIC PATIENTS UNDERGOING ENDOSCOPIC BAND LIGATION. (2018) (0)
- 492 REGULATION OF LIVER GRAFT CHOLESTEROL SYNTHESIS AND UPTAKE AFFECTS THE OUTCOME OF HUMAN LIVER TRANSPLANTATION (2010) (0)
- Reply to: “The Possible Role of Anti-methicillin-resistant Staphylococus Aureus Antimicrobial Agents in Spontaneous Bacterial Peritonitis” (2015) (0)
- Nutrient intake, phisical activity & nutritional state in cirrhotic patients (2000) (0)
- 620 IS THE DIAGNOSIS OF IDIOPATHIC NON-CIRRHOTIC PORTAL HYPERTENSION BE CONSIDERED IN PATIENTS WITH PRIMARY ANTIBODY DEFICIENCIES? (2013) (0)
- Reply to: "Myokines: a promising therapeutic target for hepatic encephalopathy". (2017) (0)
- Protein Catabolism and the Dysregulation of Energy Intake-Related Hormones May Play a Major Role in the Worsening of Malnutrition in Hospitalized Cirrhotic Patients (2022) (0)
- P542 STUDY OF THE VENTRICULAR MECHANIC WITH 3D-SPECKLE TRACKING ECHOCARDIOGRAPHY IN CIRRHOTIC PATIENTS: A POSSIBLE TOOL FOR THE DIAGNOSIS OF CIRRHOTIC CARDIOMYOPATHY (2014) (0)
- SAT-039-The assessment of sarcopenia by quadriceps muscle ultrasound in patients with liver cirrhosis (2019) (0)
- PA.187 SEQUENTIAL CHANGES IN NUTRITIONAL STATUS, ENERGY EXPENDITURE, DIETARY INTAKE DURING THE FIRST SIX MONTHS AFTER LIVER TRANSPLANTATION (2008) (0)
- 113 OLDER DONOR AGE IS ASSOCIATED WITH INCREASED DONOR OXIDATIVE STRESS AND FAILURE TO RESTORE BASAL PROTEIN GRAFT CONTENT AFTER ISCHEMIA REPERFUSION IN HUMAN LIVER TRANSPLANTATION (2008) (0)
- PA.192 CALCINEURIN INHIBITORS REDUCTION IN LIVER TRANSPLANTED PATIENTS WITH CHRONIC RENAL DYSFUNCTION: RESULTS IN CURRENT CLINICAL PRACTICE (2008) (0)
- FRI-398-Impact of sarcopenia and myosteatosis on post-transplant complications and survival (2019) (0)
- 16 Donor arterial oxygen pressure is a major determinant of early post-operative adverse events in adult liver transplant recipients (2003) (0)
- Corrigendum to “Sarcopenia in non-alcoholic fatty liver disease: Targeting the real culprit?” [J Hepatol 63 (2015) 309–311] (2015) (0)
- Intractable hepatic encephalopathy after tips with polytetrafluoroethylene-covered stent-graft. (2003) (0)
- Natural history of low risk esophageal varices in cirrhotic patients (2000) (0)
- EFFECT OF RIBAVIRIN PRE-TREATMENT ON EARLY VIROLOGICAL RESPONSE OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION (2009) (0)
- 464 CHRONIC RENAL DYSFUNCTION AFTER LIVER TRANSPLANTATION: RISK FACTORS AND A NEW PREDICTIVE SCORE (2009) (0)
- The use of non-selective beta-blockers in patients with cirrhosis: more doubts than certainties (2017) (0)
- T06.01.11 THE QUADRICEPS MUSCLE ULTRASOUND IN THE DIAGNOSIS OF SARCOPENIA IN PATIENTS WITH LIVER CIRRHOSIS (2020) (0)
- Leptin in cirrhotic patients (2000) (0)
- 172 PROPHYLAXIS WITH BETA-BLOCKERS AND LOWER USE OF PROTON PUMP INHIBITORS MAY REDUCE THE PREVALENCE OF INFECTIONS IN CIRRHOTIC PATIENTS (2011) (0)
- COVID-19 in Liver Transplant Candidates: Pre- and Post-Transplant Outcome (2021) (0)
- Graft HCV reinfection impairs the physiological increase of insulin hepatic extraction and pancreatic secretion rapidly occurring after liver transplantation (2006) (0)
- Recipient and donor gender match predicts the outcome of antiviral therapy for recurrent hepatitis C (2014) (0)
- Role of AKI in patients with decompensated cirrhosis: Preliminary results from a prospective study in two Italian University Hospitals (2016) (0)
- Acute hepatitis B in a patient with OLT during treatment with peg-interferon and ribavirin for hepatitis C recurrence (2012) (0)
- Energy expenditure and caloric intake in patients with stable cirrhosis with or without malnutrition (2000) (0)
- Pregnancy after liver transplantation: a survey from Italian liver transplants centres (2021) (0)
- P.1.318: CHANGES IN BODY COMPOSITION IN THE FIRST MONTHS AFTER LIVER TRANSPLANTATION (2011) (0)
- PA.110 FACTORS INFLUENCING SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN FOR RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION (2008) (0)
- LACK OF RESPONSE TO DOUBLE DOSE HBV VACCINATION IN PATIENTS TRANSPLANTED FOR HEPATITIS B END STAGE LIVER DISEASE. (2004) (0)
- The Microscopical Detection of Bacteria Components in Clinical Samples might be Useful to Predict the Risk of Infection (2016) (0)
- OC-15 Videocapsule endoscopy in patients with portal hypertension: small bowel findings before and following transgiugular intrahepatic portosystemic shunt (2012) (0)
- 165 MELD, PROTEIN MALNUTRITION AND PREVIOUS INFECTIONS ARE PREDICTORS OF BACTERIAL INFECTIONS AND SEPSIS IN CIRRHOTIC PATIENTS (2010) (0)
- Preliminary results of the effects of beta-hydroxy-beta-methylbutyrate supplementation in patients with liver cirrhosis: a randomized controlled pilot study (2020) (0)
- Bone density and nutritional assessment in cirrhotic patients (2001) (0)
- Sustained virological response with DAAs decreases glucose level but do not improve renal function, lipid metabolism and blood pressure in liver transplanted patients: a 3-year, long-term follow up (2020) (0)
- A comparison of cell blood analyzer and manual hemacytometer for polymorphonuclear cell count in the ascttic fluid in cirrhotic patients with and without spontaneous bacterial peritonitis (2001) (0)
- No effect of albumin infusion on the prevention of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (2015) (0)
- PA.86 AUTOIMMUNE DE NOVO HEPATITIS IN TRANSPLANTED PATIENTS FOLLOWING ANTIVIRAL TREATMENT FOR HEPATITIS C RECURRENCE (2008) (0)
- Adherence to EASL antibiotic treatment recommendations improves the outcomes of patients with cirrhosis and bacterial infections : results from the ICA 'Global Study' (2018) (0)
- HEMODYNAMIC CHANGES DURING A SINGLE MARS TREATMENT IN PATIENTS WITH ACUTE LIVER FAILURE (2004) (0)
- Is Protein Malnutrition a Negative Prognostic Factor in Compensated Cirrhotic Patients? A Retrospective Analysis Answering to the Proposal of the Italian Consensus on Portal Hypertension (Baveno VI) (2016) (0)
- 192 INHIBITORY CONTROL TEST DOES NOT IDENTIFY THE PATIENTS AT RISK OF DEVELOPING OVERT HE IN AN ITALIAN POPULATION OF CIRRHOTIC PATIENTS (2010) (0)
- PREHARVEST DONOR ARTERIAL HYPEROXIA AMELIORATES GRAFT SURVIVAL IN LIVER TRANSPLANTATION BY REDUCING NITRIC OXIDE SINTHASE LIVER EXPRESSION BEFORE GRAFT ISCHEMIA (2004) (0)
- F-24 Acoustic radiation force impluse (ARFI) vs. Fibroscan (FS) in detection of severe fibrosis in ortotopic liver transplant: preliminary results (2013) (0)
- P921 NEGATIVE PROGNOSTIC IMPACT OF HEPATIC ENCEPHALOPATHY IN CIRRHOSIS: IS IT TIME TO IMPLEMENT THE MELD SCORE TO IMPROVE THE TRANSPLANT BENEFIT? (2014) (0)
- Blood ammonia is increases by sodium benzoate in cirrhotic patients (2000) (0)
- Validation of a model predicting survival in patients with tips (2001) (0)
- Treatment of CRKP infections in cirrhotic patients (2021) (0)
- P.18.2 LONG-TERM MAINTENANCE OF SVR IN DIFFICULT-TO-TREAT HCV GENOTYPES IN LIVER TRANSPLANT RECIPIENTS WITH HCV RECURRENCE (2013) (0)
- 187 SEPSIS REPRESENTS A NEGATIVE PROGNOSTIC FACTOR IN SHORT AND LONG TERM IN HOSPITALIZED CIRRHOTIC PATIENTS (2011) (0)
- 598 IN VITRO EFFECT OF n-6/n-3 POLYUNSATURATED FATTY ACIDS ON PLATELET NOX2-MEDIATED OXIDATIVE STRESS IN LIVER CIRRHOSIS (2013) (0)
- Accurate assessment of cardiac function and myocardial fibrosis in liver cirrhosis by contrast-enhanced cardiac magnetic resonance (2007) (0)
- [Gamma-aminobutyric acid (GABA) in the pathogenesis of hepatic encephalopathy]. (1987) (0)
- 667 TERLIPRESSIN AND ALBUMIN VS MIDODRINE PLUS OCTREOTIDE AND ALBUMIN IN THE TREATMENT OF HRS IN PATIENTS WITH CIRRHOSIS: RESULTS OF A CONTROLLED CLINICAL TRIAL BY AISF (2012) (0)
- Prevention of early post-tips hepatic encefalopathy: Comparation betinefn rifaximin, lactitol and no treatment (2001) (0)
- Dual antiviral therapy in haematological patients with protracted SARS-CoV-2 infection. (2023) (0)
- F.N.8 INHIBITORY CONTROL TEST DOES NOT IDENTIFY THE PATIENTS AT RISK OF DEVELOPING OVERT HEPATIC ENCEPHALOPATHY (HE) IN AN ITALIAN POPULATION OF CIRRHOTIC PATIENTS (2010) (0)
- Older donor age is associated with increased donor oxidative stress and failure to restore basal total protein graft content after ischemia reperfusion injury in human liver transplantation (2008) (0)
- Sarcopenia is Associated With Hyperammoniemia and Minimal Hepatic Encephalopathy in Cirrhosis (2017) (0)
- First and second generation non absorbable disaccharides in the treatment of hepatic encephalopathy. (1990) (0)
- 427 TREATMENT OF HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: GENDER ISSUE ON THERAPY OUTCOME (2011) (0)
- Efficacy of AISF guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice (2008) (0)
- Sodium benzoate increases blood ammonia levels in cirrhotic patients (2000) (0)
- First post-transplant day ALT serum concentration predicts early hepatitis C recurrence after liver transplantation (LT) (2003) (0)
- What is new about diet in hepatic encephalopathy (2015) (0)
- Effects Q1 of Albumin Q2 Treatment Q3 on Systemic and Portal Hemodynamics and Systemic In fl ammation in Patients With Decompensated Cirrhosis (2019) (0)
- P.1.5: POOR ADHERENCE TO PEGYLATED INTERFERON AND RIBAVIRIN IS A MAJOR CONCERN IN THE TREATMENT OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION: EVIDENCE FROM THE AISF RECOLT-C STUDY GROUP (2011) (0)
- The effects of tips on neurohumoral system related to the hyperdynamic circulation of liver cirrhosis (2001) (0)
- Ribavirin Transporter [Ent1] Polymorphism is a Pretreatment Predictorof Virologic Response: The Specific Role of Donor Liver Transporter (2016) (0)
- Depression, anxiety and alexithymia symptoms are major determinants of health related quality of life (HRQoL) in cirrhotic patients (2013) (0)
- Dynamic change in the NS3 protease domain in HIV/HCV-coinfected patients naïve to anti-HCV protease inhibitors. (2017) (0)
- New indications for TIPSs: what do we know so far? (2023) (0)
- Effects of Branched Chain Amino Acids on Biochemical Variables and Clinical Symptoms of Hepatic Encephalopathy (1983) (0)
- VALIDATION AND PROGNOSTIC VALUE OF SIMPLIFIED PSYCHOMETRIC HEPATIC ENCEPHALOPATHY SCORE (SPHES) FOR THE DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY (2010) (0)
- The effect of new infection control measures for the prevention of hospital acquired infections in cirrhotic patients (2018) (0)
- T06.01.18 EFFECTS OF BETA-HYDROXY-BETA-METHYLBUTYRATE SUPPLEMENTATION IN PATIENTS WITH LIVER CIRRHOSIS: A RANDOMIZED CONTROLLED PILOT STUDY (2020) (0)
- A broad spectrum antibiotic therapy as empirical treatment in Healthcare-Associated infections improves survival in cirrhotic patients: a randomized trial (2015) (0)
- P.235 INHIBITORY CONTROL TEST DOES NOT IDENTIFY THE PATIENTS AT RISK OF DEVELOPING OVERT HE IN AN ITALIAN POPULATION OF CIRRHOTIC PATIENTS (2010) (0)
- PPIs in cirrhosis: more evidences for a careful prescription! (2019) (0)
- T-35 Cirrhotic patients fail to regain muscle mass after liver transplantation (2013) (0)
- 197 FACTORS RELATED TO HOSPITALIZATION BUT NOT THE SEVERITY OF THE LIVER DISEASE INCREASE THE RISK OF NOSOCOMIAL INFECTION IN CIRRHOTIC PATIENTS (2013) (0)
- Presence of sarcopenia is associated with development of acute-on-chronic liver failure in the NEPTUN cohort (2019) (0)
- Post prandial energy expenditure and substrate utilization in cirrhotic patients after a mixed meal (1989) (0)
- 213 BETABLOCKERS AND A PROPER USE OF PROTON PUMP INHIBITORS MAY REDUCE THE RISK OF BACTERIAL INFECTIONS IN CIRRHOTIC PATIENTS (2013) (0)
- PA.101 SUCCESSFUL COMBINED LONG TERM PROPHYLAXIS WITH LAMIVUDINE AND LOW DOSE HEPATITIS B IM IMMUNOGLOBULIN IN PATIENTS TRANSPLANTED FOR HBV CHRONIC LIVER DISEASE (2008) (0)
- Infection prevention and control programme and COVID-19 measures: Effects on hospital-acquired infections in patients with cirrhosis (2023) (0)
- Pre‐primary and Primary Prophylaxis: What Has Been Done? (2010) (0)
- The impact of IL-28B polymorphism and diabetes on SVR after antiviral therapy (AT) for post-liver transplant (LT) HCV recurrence (2014) (0)
- OC.13.9: Sarcopenia Represents a Risk Factor for the Development of Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt (2017) (0)
- MELDNa score is associated with psychopathology and reduced quality of life in cirrhotic patients with a liver transplant perspective (2017) (0)
- The effect of directly acting antivirals treatment on inflammatory status in HCV-infected patients, including those with recurrence of HCV-infection after liver transplantation: preliminary results of a prospective monocentric pilot study (2017) (0)
- 155 Predictors of outcome of liver transplantation in patients with liver cirrhosis and hepatocellular carcinoma (2004) (0)
- The diagnosis of sarcopenia by quadriceps muscle ultrasound in patients with liver cirrhosis (2020) (0)
- 540 VALIDATION OF A PREDICTIVE MODEL FOR CHRONIC RENAL DYSFUNCTION FOLLOWING LIVER TRANSPLANTATION (2011) (0)
- Short-term changes in nutritional status, energy expenditure, dietary intake in patients undergoing liver transplantation (2007) (0)
- Acute rejection on immune-mediated chronic rejection after liver transplantation (2021) (0)
- Safe pregnancy after liver transplantation: Evidence from a multicenter Italian collaborative study. (2021) (0)
- Donor arterial oxygen pressure is a major determinant of early post-operative adverse events in adult liver transplant recipients (2003) (0)
- Presence of multiple bacterial markers in clinical samples might be useful for presumptive diagnosis of infection in cirrhotic patients with culture-negative reports (2016) (0)
- Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study (2012) (0)
- Treatment of healthcare associated urinary tract infections: May an empirical broad spectrum antibiotic therapy improve survival? An analysis by a randomized trial (2016) (0)
- 160 ONE MONTH POST-OPERATIVE SERUM INSULIN PREDICTS SERUM AMINOTRANSFERASE ELEVATION AND FIBROSIS PROGRESSION DUE TO HCV RECURRENCE AFTER LIVER TRANSPLANTATION (2009) (0)
- FRI-369-The role of adipose tissue in metabolic and cardiovascular complication after liver transplantation (2019) (0)
- Staphylococcus aureus antimicrobial agents in spontaneous bacterial peritonitis (2015) (0)
- The Pros and the Cons of the Amino Acid Neurotransmitter Hypothesis (1984) (0)
- 164 POST-TRANSPLANTATION METABOLIC SYNDROME: IS IT ONLY A THERAPEUTIC CONCERN? (2012) (0)
- SHORT TERM EFFECTS OF CONVERSION FROM TWICE-DAILY TO ONCE-DAILY TACROLIMUS FORMULATION IN LIVER TRANSPLANT PATIENTS (2009) (0)
- One month post-operative serum insulin predicts serum aminotransferase elevation and fibrosis progression due to HCV recurrence after liver transplantation (2009) (0)
- A functional metagenomics investigation of cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy (2018) (0)
- Progression of low risk of esophageal varices in cirrhotic patients (2001) (0)
- CS.1.4 A PROSPECTIVE ITALIAN SURVEY ON HEPATORENAL SYNDROME (2010) (0)
- 460 RECIPIENT MTHFR C677T POLYMORPHISM PREDICTS PRE-TRANSPLANT CIRRHOSIS PROGRESSION AND SURVIVAL AFTER LIVER TRANSPLANTATION (2010) (0)
- CHRONIC RENAL DYSFUNCTION AFTER LIVER TRANSPLANTATION: RISK FACTORS AND A NEW PREDICTIVE SCORE (2009) (0)
- P193 Quality of care in inflammatory bowel disease in Italy according to IBD characteristics: Initial results from SOLUTION trial (an ongoing prospective IG-IBD study) (2012) (0)
- The Improvement of Nutritional Status of Cirrhotic Patients After Transjugular Intrahepatic Portosysthemic Shunt is Associated With the Amelioration of Cognitive Impairment (2017) (0)
- O8 RISK FACTORS FOR NOSOCOMIAL INFECTION IN CIRRHOTIC PATIENTS: A PROSPECTIVE STUDY (2012) (0)
- Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with ACLF across Europe (2018) (0)
- 23 OC Management of liver disease (HCV, HBV) in patients in waiting list for renal transplantatio (2002) (0)
- Protein Malnutrition Is Involved in A An Increased Prevalence of Neurocognitive Impairment in Compensated Cirrhotic Patients. A Retrospective Analysis Answering to the Proposal of the Last Consensus on Portal Hypertension (Baveno VI) (2017) (0)
- Proceedings from the 2018 Canadian Association for the Study of the Liver Single Topic Conference-Decompensated cirrhosis: from clinic to transplant. (2019) (0)
- F.N.47 REGULATION OF LIVER GRAFT CHOLESTEROL SYNTHESIS AND UPTAKE AFFECTS THE OUTCOME OF HUMAN LIVER TRANSPLANTATION (2010) (0)
- Combining amplicon sequencing and metabolomics in cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy (2018) (0)
- OC.12.2 PATIENTS' AND PHYSICIANS' VIEWS ON QUALITY OF CARE IN INFLAMMATORY BOWEL DISEASE: INITIAL RESULTS FROM AN ONGOING PROSPECTIVE IG-IBD STUDY (2012) (0)
- Influence of sex in alcohol‐related liver disease: Pre‐clinical and clinical settings (2023) (0)
- Hepatic Encephalopathy in Patients with Non-Cirrhotic Portal Hypertension: Grade, Prevalence and Risk Factors (2016) (0)
- P.16.13 PROTEIN MALNUTRITION IS ASSOCIATED TO A WORSE PROGNOSIS IN PATIENTS WITH CIRRHOSIS CHILD A–B AND SEPSIS (2014) (0)
- P0110 : Activation of myostatin and MuRF-1 is involved in muscle wasting in mice model of primary biliary cirrhosis (2015) (0)
- Predictive risk factors of recurrence of hepatocellular carcinoma after liver transplantation (2009) (0)
- Lactitol in the Prevention of Recurrent Hepatic Encephalopathy in Shunted Cirrhotic Patients. Preliminary Results of a Controlled Trial (1987) (0)
- Comparison of skeletal muscle index (SMI) and transversal psoas muscle thickness (TPMT) for the diagnosis of sarcopenia in cirrhosis (2020) (0)
- 589 Oxidative Stress and Inflammation in Liver Cirrhosis: Role of N-6/N-3 Polyunsaturated Fatty Acids Balance (2012) (0)
- Reply (2019) (0)
- Incidence and progression of portal hypertensive gastropathy in patients with liver cirrhosis (2001) (0)
- Transjugular intrahepatic portosystemic shunt (TIPS) is feasible in non-cirrhotic patients with cavernomatous tranformation of the portal vein (2008) (0)
- 176 BACTERIAL INFECTIONS AND SEPSIS ACUTELY DETERIORATE LIVER FUNCTION IN CIRRHOTIC PATIENTS: A PROSPECTIVE STUDY (2010) (0)
- CONCURRENT SESSION 79: THE CHALLENGE OF HEPATITIS B AND C IN TRANSPLANTATION (2006) (0)
- Transjugular intrahepatic porta-systemic shunt (TIPS) VS.endoscopic sclerotherapy (ES) for the prevention of variceal rebleeding in cirrhosis: A meta-analysis using individual data of 432 patients from 5 randomized controlled trials (2000) (0)
- Italian survey on HBV and liver transplantation in a cohort of 2260 patients (2014) (0)
- The effect of beta-hydroxy-beta-methyl butyrate supplementation on muscle wasting in patients undergoing liver transplantation: results of preliminary analysis (2017) (0)
- PREHARVEST DONOR ARTERIAL HYPEROXIA PROTECTS FROM INITIAL POOR GRAFT FUNCTION AFTER LIVER TRANSPLANTATION BY INCREASING TOTAL PROTEIN LIVER CONCENTRATION (2004) (0)
- Acquired cow’s milk sensitization after liver transplant in an adult: “clinical implications” and future strategies (2019) (0)
- Activation of proinflammatory citokines is involved in muscle wasting in mice model of carbon tetrachloride induced liver cirrhosis (2017) (0)
- P.1.276: ALBUMIN ADMINISTRATION SUPPORTS CARDIAC OUTPUT IN CIRRHOTIC PATIENTS AFTER TOTAL PARACENTESIS (2011) (0)
- Ustekinumab for the treatment of moderate‐to‐severe plaque psoriasis in a solid organ transplanted recipient: A case report (2021) (0)
- In Memoriam Prof. Dr. med., Dr. med. h.c. Walter Brendel (1989) (0)
- The impact of multidisciplinary support to alcohol misusers at risk of alcohol relapse after liver transplantation (2017) (0)
- 165 DONOR/RECIPIENT BODY SURFACE AREA RATIO AS A NOVEL PREDICTOR OF GRAFT SURVIVAL AFTER DECEASED DONOR LIVER TRANSPLANTATION (2009) (0)
- Impact of an antimicrobial stewardship policy on the reduction of empirical antibiotic treatment failure and the spread of multidrug-resistant organisms in hospitalized cirrhotic patients (2018) (0)
- ANTIVIRAL TREATMENT MAY IMPROVE THE OUTCOME OF PATIENTS WITH RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION (2009) (0)
- A randomized controlled trial of Transjugular Intrahepatic Portosystemic Shunt (TIPS) vs paracentesis in the treatment of refractory ascites: Preliminary results (2000) (0)
- P.03.5 RECIPIENT SERUM TOTAL AND LDL CHOLESTEROL CONCENTRATION AT TRANSPLANT PREDICTS GRAFT SURVIVAL AFTER LIVER TRANSPLANTATION INDEPENDENTLY FROM MELD SCORE (2012) (0)
- Zinc status in carbon tetrachloride-induced liver cirrhosis in the rat (1990) (0)
- SAT-088-Sarcopenia and Myosteatosis are associated with minimal and overt hepatic encephalopathy in patients with liver cirrhosis (2019) (0)
- Diet Therapy in Patients with Liver Disease and Liver Transplant (2010) (0)
- 31 CLINICAL EFFICACY OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT CREATED WITH COVERED STENTS WITH DIFFERENT DIAMETERS: RESULTS OF A RANDOMIZED CONTROLLED TRIAL (2010) (0)
- Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET) (2023) (0)
- OC.11.5 RECIPIENT MTHFR C677T POLYMORPHISM PREDICTS PRE-TRANSPLANT CIRRHOSIS PROGRESSION AND SURVIVAL AFTER LIVER TRANSPLANTATION (2010) (0)
- 3D-Speckle Tracking Echocardiography in cirrhotic patients: A possible tool for the diagnosis of cirrhotic cardiomyopathy (2014) (0)
- O3 THE IMPACT OF MALNUTRITION ON THE OUTCOME OF CIRRHOTIC PATIENTS WITH INFECTIONS (2012) (0)
- Accuracy of the mayo clinic model to predict survival in patients with elective tips (2001) (0)
- New and old therapy against Carbapenemase-Producing Klebsiella pneumoniae (kpc) infections in the cirrhotic patient: a retrospective analysis (2020) (0)
- Nutrition and Chronic Liver Disease (2018) (0)
- Donor/recipient body surface area ratio as a novel predictor of graft survival after deceased donor liver transplantation (2009) (0)
- ' s report Title : Anthropometric , biochemical and clinical assessment of malnutrition in Malaysian patients with advanced cirrhosis Version : 1 Date : 18 January 2010 (0)
- The Impact of Transjugular Intrahepatic Portosystemic Shunt on Nutrition in Liver Cirrhosis Patients: A Systematic Review (2023) (0)
- Prevalence and clinical relevance of spontaneous porto-systemic shunts in cirrhotic patients with recurrent hepatic encephalopathy: A case control study (2003) (0)
- Prevention of hepatic encephalopathy after porto-systemic shunt (2006) (0)
- Consensus Statements: Changing Scenarios: Prevention of Decompensation (2016) (0)
- Staphylococcus aureus in a patient with cirrhosis: the potential role for daptomycin and review of the literature (2015) (0)
- Early hepatocyte C4d expression and failure to restore basal hepatic total protein content after ischaemia–reperfusion are associated with 1-year graft loss in human liver transplantation (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Manuela Merli?
Manuela Merli is affiliated with the following schools:
